Ravels, Belgium

Gasto S Diels

This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gasto S Diels. Retrieved from https://idiyas.com/inventor/gasto-s-diels

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Gasto S Diels: Innovator in Pharmacological Research

Introduction

Gasto S Diels is a notable inventor based in Ravels, Belgium. He has made significant contributions to the field of pharmacology, particularly in the development of compounds with anti-histaminic properties. His work has implications for treating allergic diseases in warm-blooded animals.

Latest Patents

Diels holds a patent for "Pharmacologically active N-(4-piperidinyl) bicyclic condensed - Novel N-(4-piperindyl)bicyclic condensed 2-imidazolamine derivatives and their pharmaceutically acceptable acid addition salts having anti-histaminic properties, compositions containing the same, and methods of treating allergic diseases in warm-blooded animals." This patent highlights his innovative approach to addressing allergic conditions through novel chemical compounds.

Career Highlights

Throughout his career, Gasto S Diels has been associated with Janssen Pharmaceutica NV, a leading pharmaceutical company. His work at Janssen has allowed him to collaborate with other experts in the field and contribute to advancements in pharmacological research.

Collaborations

Some of his notable coworkers include Frans E Janssens and Joseph L Torremans. Their collaborative efforts have further enhanced the research and development of new therapeutic agents.

Conclusion

Gasto S Diels is a distinguished inventor whose work in pharmacology has the potential to improve treatment options for allergic diseases. His innovative contributions continue to influence the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…